Millipore Corporation Announces Technology Acquisition to Strengthen Drug Discovery Product Offering
BILLERICA, Mass.--(BUSINESS WIRE)--Millipore Corporation (NYSE: MIL), a leading provider of technologies, tools and services for the global life science industry, today announced that it has purchased the assets associated with Epitome Biosystems’ EpiTag™ technology. The purchase price was not disclosed.